Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?

Affiliations

¹ Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
² VA Medical Center and University of Colorado, Denver, Colorado, USA.
³ Private Practice in Family Medicine, Toronto, Canada.
⁴ Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.

Editorial

Alain Nordmann et al. Heart. 2016 May.

. 2016 May;102(9):653-4.

doi: 10.1136/heartjnl-2015-307781. Epub 2016 Feb 23.

¹ Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
² VA Medical Center and University of Colorado, Denver, Colorado, USA.
³ Private Practice in Family Medicine, Toronto, Canada.
⁴ Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.

No abstract available

Comment on

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Schwartz GG, et al. JAMA. 2001 Apr 4;285(13):1711-8. doi: 10.1001/jama.285.13.1711. JAMA. 2001. PMID: 11277825 Clinical Trial.